Senti Biosciences, Inc. Stock Analysis & AI Score
Senti Biosciences, Inc. (SNTI) has an ST Score of 35.7 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $6.00 price target (+2252.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AISNTI Stock Price History
SNTI Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
SNTI Latest Stock News
ST Score
Senti Biosciences, Inc. (SNTI) has an ST Score of 35.7 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $6.00 price target (+2252.9% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- GrowthB
- ValuationC
- Financial StrengthC-
- MomentumD-
- ProfitabilityF
- Piotroski2/9
Press Releases
Company Contact Details
SNTI stock: frequently asked questions
What is SNTI's ST Score?
Senti Biosciences, Inc. (SNTI) has an ST Score of 35.7 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SNTI a buy, hold, or sell?
Analysts rate SNTI a Buy, with a price target of $6.00 (+2252.9% vs the current price). Our ST Score grades it C- (35.7/100). The ST Score is a data-driven signal, not a recommendation.
What are SNTI's factor grades?
Valuation C, Profitability F, Financial Strength C-, Momentum D-, Growth B, Forecast A.
What is SNTI's valuation grade?
Senti Biosciences, Inc. (SNTI) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SNTI's growth grade?
Senti Biosciences, Inc. (SNTI) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SNTI's profitability grade?
Senti Biosciences, Inc. (SNTI) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SNTI's financial strength grade?
Senti Biosciences, Inc. (SNTI) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SNTI?
The average analyst price target for Senti Biosciences, Inc. (SNTI) is $6.00 from 4 analysts, which is +2252.9% versus the recent price of $0.26.
What is SNTI's Piotroski score?
Senti Biosciences, Inc. (SNTI) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.